Determining the Axillary Nodal Status with 4 Current Imaging Modalities, Including 18F-FDG PET/MRI, in Newly Diagnosed Breast Cancer: A Comparative Study Using Histopathology as the Reference Standard

被引:12
|
作者
Morawitz, Janna [1 ]
Bruckmann, Nils-Martin [1 ]
Dietzel, Frederic [1 ]
Ullrich, Tim [1 ]
Bittner, Ann-Kathrin [2 ]
Hoffmann, Oliver [2 ]
Mohrmann, Svjetlana [3 ]
Haeberle, Lena [4 ,5 ]
Ingenwerth, Marc [6 ,7 ]
Umutlu, Lale [8 ]
Fendler, Wolfgang Peter [9 ,10 ]
Fehm, Tanja [3 ]
Herrmann, Ken [9 ,10 ]
Antoch, Gerald [1 ]
Sawicki, Lino Morris [1 ]
Kirchner, Julian [1 ]
机构
[1] Univ Dusseldorf, Dept Diagnost & Intervent Radiol, Dusseldorf, Germany
[2] Univ Duisburg Essen, Univ Hosp Essen, Dept Gynecol & Obstet, Essen, Germany
[3] Univ Dusseldorf, Dept Gynecol, Dusseldorf, Germany
[4] Heinrich Heine Univ, Inst Pathol, Dusseldorf, Germany
[5] Univ Hosp Duesseldorf, Dusseldorf, Germany
[6] Univ Duisburg Essen, Univ Hosp Essen, Inst Pathol, West German Canc Ctr, Essen, Germany
[7] German Canc Consortium, Essen, Germany
[8] Univ Duisburg Essen, Dept Diagnost & Intervent Radiol & Neuroradiol, Univ Hosp Essen, Essen, Germany
[9] Univ Duisburg Essen, Dept Nucl Med, Essen, Germany
[10] German Canc Consortium Univ Hosp Essen, Essen, Germany
关键词
breast cancer; axillary lymph node metastasis; PET/MRI; oncologic imaging; LYMPH-NODES; BIOPSY; METASTASIS;
D O I
10.2967/jnumed.121.262009
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The purpose of this study was to compare breast MRI, thoracic MRI, thoracic F-18-FDG PET/MRI, and axillary sonography for the detection of axillary lymph node metastases in women with newly diagnosed breast cancer. Methods: This prospective double-center study included patients with newly diagnosed breast cancer between March 2018 and December 2019. Patients underwent thoracic (F-18-FDG PET/)MRI, axillary sonography, and dedicated prone breast MRI. Datasets were evaluated separately regarding nodal status (nodal-positive vs. nodal-negative). Histopathology served as the reference standard in all patients. The diagnostic performance of breast MRI, thoracic MRI, thoracic PET/MRI, and axillary sonography in detecting nodal-positive patients was tested by creating receiver-operating-characteristic curves (ROC) with a calculated area under the curve (AUC). Sensitivity, specificity, positive predictive value, negative predictive value, and accuracy were calculated for all 4 modalities. A McNemar test was used to assess differences. Results: In total, 112 female patients (mean age, 53.04 +/- 12.6 y) were evaluated. Thoracic PET/MRI showed the highest AUC, with a value of 0.892. The AUCs for breast MRI, thoracic MRI, and sonography were 0.782, 0.814, and 0.834, respectively. Differences between thoracic PET/MRI and axillary sonography, thoracic MRI, and breast M Rlwere statistically significant (PET/MRI vs. axillary sonography, P = 0.01; PET/MRI vs. thoracic MRI, P = 0.02; PET/MRI vs. breast MRI, P = 0.03). PET/MRI showed the highest sensitivity (81.8% [36/44]; 95% CI, 67.29%-91.81%), whereas axillary sonography had the highest specificity (98.5% [65/66]; 95% CI, 91.84%-99.96%). Conclusion: F-18-FDG PET/MRI outperforms axillary sonography, breast MRI, and thoracic MRI in determining the axillary lymph node status. In a clinical setting, the combination of F-18-FDG PET/MRI and axillary sonography might be considered to provide even greater accuracy in diagnosis.
引用
收藏
页码:1677 / 1683
页数:7
相关论文
共 33 条
  • [1] Conventional Imaging, MRI and 18F-FDG PET/MRI for N and M Staging in Patients with Newly Diagnosed Breast Cancer
    Morawitz, Janna
    Bruckmann, Nils-Martin
    Jannusch, Kai
    Dietzel, Frederic
    Milosevic, Aleksandar
    Bittner, Ann-Kathrin
    Hoffmann, Oliver
    Mohrmann, Svjetlana
    Ruckhaeberle, Eugen
    Haeberle, Lena
    Fendler, Wolfgang Peter
    Herrmann, Ken
    Giesel, Frederik Lars
    Antoch, Gerald
    Umutlu, Lale
    Kowall, Bernd
    Stang, Andreas
    Kirchner, Julian
    CANCERS, 2023, 15 (14)
  • [2] Comparison of nodal staging between CT, MRI, and [18F]-FDG PET/MRI in patients with newly diagnosed breast cancer
    Janna Morawitz
    Nils-Martin Bruckmann
    Frederic Dietzel
    Tim Ullrich
    Ann-Kathrin Bittner
    Oliver Hoffmann
    Eugen Ruckhäberle
    Svjetlana Mohrmann
    Lena Häberle
    Marc Ingenwerth
    Daniel Benjamin Abrar
    Lino Morris Sawicki
    Katharina Breuckmann
    Wolfgang Peter Fendler
    Ken Herrmann
    Christian Buchbender
    Gerald Antoch
    Lale Umutlu
    Julian Kirchner
    European Journal of Nuclear Medicine and Molecular Imaging, 2022, 49 : 992 - 1001
  • [3] Comparison of nodal staging between CT, MRI, and [18F]-FDG PET/MRI in patients with newly diagnosed breast cancer
    Morawitz, Janna
    Bruckmann, Nils-Martin
    Dietzel, Frederic
    Ullrich, Tim
    Bittner, Ann-Kathrin
    Hoffmann, Oliver
    Ruckhaeberle, Eugen
    Mohrmann, Svjetlana
    Haeberle, Lena
    Ingenwerth, Marc
    Abrar, Daniel Benjamin
    Sawicki, Lino Morris
    Breuckmann, Katharina
    Fendler, Wolfgang Peter
    Herrmann, Ken
    Buchbender, Christian
    Antoch, Gerald
    Umutlu, Lale
    Kirchner, Julian
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (03) : 992 - 1001
  • [4] Clinical Decision Support for Axillary Lymph Node Staging in Newly Diagnosed Breast Cancer Patients Based on 18F-FDG PET/MRI and Machine Learning
    Morawitz, Janna
    Sigl, Benjamin
    Rubbert, Christian
    Bruckmann, Nils-Martin
    Dietzel, Frederic
    Haeberle, Lena J.
    Ting, Saskia
    Mohrmann, Svjetlana
    Ruckhaeberle, Eugen
    Bittner, Ann-Kathrin
    Hoffmann, Oliver
    Baltzer, Pascal
    Kapetas, Panagiotis
    Helbich, Thomas
    Clauser, Paola
    Fendler, Wolfgang P.
    Rischpler, Christoph
    Herrmann, Ken
    Schaarschmidt, Benedikt M.
    Stang, Andreas
    Umutlu, Lale
    Antoch, Gerald
    Caspers, Julian
    Kirchner, Julian
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64 (02) : 304 - 311
  • [5] A comparative study of 18F-FDG PET/CT and ultrasonography in the diagnosis of breast cancer and axillary lymph node metastasis
    He, Xinjia
    Sun, Lixia
    Huo, Yanlei
    Shao, Mei
    Ma, Chao
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 61 (04): : 429 - 437
  • [6] Diagnostic Value of Axillary Ultrasound, MRI, and 18F-FDG- PET/CT in Determining Axillary Lymph Node Status in Breast Cancer Patients
    Aktas, Aysegul
    Gurleyik, Meryem Gunay
    Aksu, Sibel Aydin
    Aker, Fugen
    Gungor, Serkan
    EUROPEAN JOURNAL OF BREAST HEALTH, 2022, 18 (01) : 37 - 47
  • [7] Added value of dedicated axillary hybrid 18F-FDG PET/MRI for improved axillary nodal staging in clinically node-positive breast cancer patients: a feasibility study
    Thiemo J. A. van Nijnatten
    B. Goorts
    S. Vöö
    M. de Boer
    L. F. S. Kooreman
    E. M. Heuts
    J. E. Wildberger
    F. M. Mottaghy
    M. B. I. Lobbes
    M. L. Smidt
    European Journal of Nuclear Medicine and Molecular Imaging, 2018, 45 : 179 - 186
  • [8] Added value of dedicated axillary hybrid 18F-FDG PET/MRI for improved axillary nodal staging in clinically node-positive breast cancer patients: a feasibility study
    van Nijnatten, Thiemo J. A.
    Goorts, B.
    Voo, S.
    de Boer, M.
    Kooreman, L. F. S.
    Heuts, E. M.
    Wildberger, J. E.
    Mottaghy, F. M.
    Lobbes, M. B. I.
    Smidt, M. L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 (02) : 179 - 186
  • [9] 18F-FES PET/CT influences the staging and management of newly diagnosed Oestrogen Receptor positive Breast Cancer Patients: A Retrospective Comparative Study with 18F-FDG PET/CT
    Liu, Cheng
    Gong, Chengcheng
    Liu, Shuai
    Xu, Xiaoping
    Yuan, Huiyu
    Zhang, Yongping
    Yang, Zhongyi
    Wang Biyun
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [10] 18F-FES PET/CT Influences the Staging and Management of Patients with Newly Diagnosed Estrogen Receptor-Positive Breast Cancer: A Retrospective Comparative Study with 18F-FDG PET/CT
    Liu, Cheng
    Gong, Chengcheng
    Liu, Shuai
    Zhang, Yingjian
    Zhang, Yongping
    Xu, Xiaoping
    Yuan, Huiyu
    Wang, Biyun
    Yang, Zhongyi
    ONCOLOGIST, 2019, 24 (12): : E1277 - E1285